Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05065151 · ClinicalTrials.gov registry record · NA

Understanding Motivation in Parkinson's Patients Through Neurophysiology

A NA study of Parkinson Disease and Deep Brain Stimulation, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05065151 is a NA study of Parkinson Disease and Deep Brain Stimulation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05065151, a NA study of Parkinson Disease and Deep Brain Stimulation, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation to effort, reward, and timing.

Interventions

  • OTHER Stimulation on
  • OTHER Stimulation off
  • BEHAVIORAL Decision Making Task

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-10-30
Est. Completion 2030-12-01
Phase NA

What the Registry Record Tells You About NCT05065151

The ClinicalTrials.gov registry entry for NCT05065151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which Stimulation on is the first listed.

NCT05065151 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05065151 about?

NCT05065151 is a clinical study titled "Understanding Motivation in Parkinson's Patients Through Neurophysiology". The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation t...

What is the current status of trial NCT05065151?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-10-30. Estimated completion is 2030-12-01.

What conditions does trial NCT05065151 study?

This clinical trial studies the following conditions: Parkinson Disease, Deep Brain Stimulation, Motivation.

What interventions are being tested in trial NCT05065151?

The interventions under investigation include: Stimulation on (OTHER), Stimulation off (OTHER), Decision Making Task (BEHAVIORAL).

Who is sponsoring clinical trial NCT05065151?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05065151 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.